Today: 26 June 2026

Click Holdings (CLIK) Jumps After Acquiring Two Hong Kong HR Firms – What Investors Need to Know Today

Click Holdings (CLIK) Jumps After Acquiring Two Hong Kong HR Firms – What Investors Need to Know Today

Click Holdings (NASDAQ: CLIK) surged on November 18, 2025, after announcing all-stock acquisitions of Bowser Human Resources and Top Team Consultants in Hong Kong, issuing 2,117,606 new shares. Trading volume topped 3.5 million, with shares in the mid-$7 range. The deals could nearly triple CLIK’s share count, raising dilution concerns. Management projects around 200% sales growth in professional services.
Microsoft, Nvidia and Anthropic Strike $45 Billion AI Mega-Deal as Claude Commits $30 Billion to Microsoft Azure

Microsoft, Nvidia and Anthropic Strike $45 Billion AI Mega-Deal as Claude Commits $30 Billion to Microsoft Azure

Anthropic will buy $30 billion in cloud computing capacity from Microsoft Azure and receive up to $15 billion in new investment from Microsoft and Nvidia. The deal gives Anthropic access to 1 gigawatt of Nvidia-powered compute on Azure and brings its Claude AI models to Microsoft’s cloud. Anthropic’s Claude becomes the only major frontier AI model available on all three leading clouds. Amazon remains Anthropic’s primary cloud partner.
Clearmind Medicine (CMND) Delivers Positive AUD Trial Data Amid New Depression Patent – Nov. 18, 2025

Clearmind Medicine (CMND) Delivers Positive AUD Trial Data Amid New Depression Patent – Nov. 18, 2025

Clearmind Medicine reported positive safety results from the first cohort of its FDA-approved Phase I/IIa trial of CMND-100 for alcohol use disorder. No serious adverse events were observed among six participants treated at Johns Hopkins and Yale. CMND shares surged to $0.39 intraday on heavy volume before settling near $0.27 by mid-afternoon November 18. The company also announced a new Israeli patent filing and an expected equity offering.
Lowe’s (LOW) Stock Slips as Wall Street Braces for Q3 2025 Earnings, Dividend and Big Fund Moves – November 18, 2025

Lowe’s (LOW) Stock Slips as Wall Street Braces for Q3 2025 Earnings, Dividend and Big Fund Moves – November 18, 2025

Lowe’s shares fell about 1% Tuesday to the low-$220s, extending a decline below key moving averages ahead of its Q3 earnings report due November 19. The company declared a $1.20 per share quarterly dividend, maintaining a 2% yield. Over the past year, Lowe’s stock has dropped roughly 16%, underperforming both Home Depot and the S&P 500. Market capitalization stands near $126–128 billion.
Gorilla Technology (GRRR) Soars on Record Q3 Earnings, $1.4B AI Data Centre Deal and Bullish 2026 Outlook

Gorilla Technology (GRRR) Soars on Record Q3 Earnings, $1.4B AI Data Centre Deal and Bullish 2026 Outlook

Gorilla Technology Group shares surged November 18 after the company reported record Q3 2025 results, including $26.5 million in revenue, a swing to positive operating income, and near-breakeven net loss. The company confirmed a $1.4 billion AI data centre mandate in Southeast Asia and reported cash of $121.4 million with debt down to $15.1 million.
NICE Ltd (NICE) Stock Hits Lowest Level Since 2019 as Wall Street Slashes Price Targets After AI-First Pivot

NICE Ltd (NICE) Stock Hits Lowest Level Since 2019 as Wall Street Slashes Price Targets After AI-First Pivot

NICE Ltd. shares plunged over 15% Tuesday to their lowest since 2019 after the company announced a $160 million increase in AI spending and warned of lower 2026 margins at its Capital Markets Day. The sell-off followed strong Q3 results but triggered fresh analyst downgrades and erased recent gains, with NICE’s valuation now down more than 30% year-to-date.
Onfolio Holdings (ONFO) Lands Up to $300 Million for Crypto Treasury as Q3 Loss Widens

Onfolio Holdings (ONFO) Lands Up to $300 Million for Crypto Treasury as Q3 Loss Widens

Onfolio secured a convertible note facility of up to $300 million from a U.S. institutional investor, with $6 million closing around Nov. 18 and $2 million more expected in 30 days. Shares fell 16.6% after Q3 results showed a wider net loss despite 36.3% revenue growth, then rebounded on the financing news. The company plans to use much of the capital for Bitcoin, Ethereum, and Solana staking. Market cap stands near $4–5 million.
Freeport-McMoRan (FCX) Rallies as Grasberg Restart Plan Offsets Class-Action Fallout – 18 November 2025

Freeport-McMoRan (FCX) Rallies as Grasberg Restart Plan Offsets Class-Action Fallout – 18 November 2025

Freeport-McMoRan shares rose up to 6% Tuesday after the company detailed a phased restart of its Grasberg Block Cave mine in Indonesia, aiming to return 2026 copper and gold output to 2025 levels. The plan follows a fatal September mud-rush that halted operations. At least two law firms are urging shareholders to join a class-action lawsuit over alleged safety misstatements.
Intuit (INTU) Stock Rises on $100M+ OpenAI Deal to Bring TurboTax and QuickBooks Into ChatGPT

Intuit (INTU) Stock Rises on $100M+ OpenAI Deal to Bring TurboTax and QuickBooks Into ChatGPT

Intuit announced a multi-year partnership with OpenAI, signing a contract worth over $100 million to integrate OpenAI’s models into its AI platform and products. TurboTax, QuickBooks, Credit Karma, and Mailchimp will be available as apps inside ChatGPT. Intuit shares rose about 1% to $652.98 after the news. Large investors, including Nomura Asset Management, increased their stakes following the announcement.
Robinhood (HOOD) Explodes 12% to Fresh Highs — Here’s What Lit the Fuse and What Comes Next (Sept 29, 2025)

Robinhood Markets (HOOD) Stock Today, November 18, 2025: Price Action, Analyst Upgrades and the 24/7 Prediction Markets Bet

Robinhood shares traded around $115 late morning on Nov. 18, stabilizing after a 21% two-week slide and Monday’s 5.3% drop. The stock remains up over 200% year-on-year, with a 52-week range of $29.66 to $153.86. Wall Street analysts raised price targets to as high as $155 after strong Q3 results and surging platform assets. Broader tech and crypto selloffs pressured markets, with the S&P 500 and Nasdaq both down.
18 November 2025
Temu Owner PDD Holdings Beats Profit Forecasts but Warns of Slower Growth as Stock Slides on Q3 2025 Results

Temu Owner PDD Holdings Beats Profit Forecasts but Warns of Slower Growth as Stock Slides on Q3 2025 Results

PDD Holdings reported Q3 2025 revenue of RMB 108.28 billion, up 9% year over year, marking a slowdown from previous growth rates. Net income rose 17% to RMB 29.33 billion, beating analyst forecasts. Shares fell as investors reacted to cooling revenue growth amid fierce competition from Alibaba and JD.com. Operating cash flow jumped to RMB 45.66 billion from RMB 27.52 billion a year earlier.
Why Verizon’s Bold 5G & AI Bets Could Spark a Telecom Revolution – And What It Means for Investors (VZ, Oct 6 2025)

Verizon Stock Today (VZ) on November 18, 2025: Price Action, 15,000 Job Cuts, Dividend Yield and Analyst Outlook

Verizon shares traded around $41.23 midday Tuesday, up 0.5%, as investors reacted to new institutional buying and continued fallout from a 15,000-job layoff plan. Volume reached 6.5 million shares, below recent averages. The stock’s dividend yield stands near 6.7%, with a P/E ratio around 8–9. Institutional filings show steady accumulation, with about 62% of the float now held by large investors.
18 November 2025
AT&T Stock Faces Crucial Test: 5G Spectrum Gamble, Fiber Expansion & Earnings Loom

AT&T Stock Today (T): Price Holds Up as Settlement Deadline Arrives and Vanguard Boosts Its Stake — November 18, 2025

AT&T shares are trading around $25.56, up 0.3% in late-afternoon trading, outperforming major U.S. indices amid a global sell-off. Vanguard has increased its stake to 661.4 million shares, while today marks the deadline for AT&T’s $177 million data-breach settlement. Trading volume stands near 9.4 million shares. The company maintains a quarterly dividend of $0.2775 per share.
18 November 2025
Can-Fite BioPharma (CANF) Soars on 9-Year Liver Cancer Survival Breakthrough with Namodenoson – November 18, 2025

Can-Fite BioPharma (CANF) Soars on 9-Year Liver Cancer Survival Breakthrough with Namodenoson – November 18, 2025

Can-Fite BioPharma shares surged over 30% Tuesday after reporting a patient with advanced hepatocellular carcinoma remained cancer-free for nine years on its drug Namodenoson. The company also began enrolling patients in a pivotal Phase III trial for the treatment in Israel, Europe, and the U.S. Namodenoson holds Orphan Drug and Fast Track designations.
Baidu (BIDU) Q3 2025 Earnings: Revenue Falls 7% as AI Cloud and Robotaxis Power a Big EPS Beat

Baidu (BIDU) Q3 2025 Earnings: Revenue Falls 7% as AI Cloud and Robotaxis Power a Big EPS Beat

Baidu reported Q3 2025 revenue of RMB 31.2 billion, down 7% year over year but above analyst estimates. The company posted a net loss of RMB 11.2 billion, mainly due to a RMB 16.2 billion impairment. Non-GAAP net income reached RMB 3.8 billion, beating expectations. AI-powered business revenue surged over 50% to nearly RMB 10 billion, while online ad revenue fell 18%.
Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Medtronic Stock Jumps Above $100 After Q2 FY26 Beat and Raised Outlook on 18 November 2025

Medtronic shares jumped 4–5% to around $100–101 late Tuesday morning, hitting a three-year high after the company beat fiscal Q2 2026 earnings and revenue forecasts and raised its full-year outlook. Revenue rose 6.6% to $9.0 billion, with adjusted EPS of $1.36 topping analyst estimates. The rally pushed Medtronic’s market cap to about $129 billion. Demand for heart and diabetes devices drove the gains.

Stock Market Today

  • 3 ASX Penny Stocks Over A$60M Market Cap to Watch
    June 25, 2026, 11:54 PM EDT. Australian penny stocks like Diatreme Resources, with a market cap of A$60.1 million, and Mesoblast Limited, valued at A$2.7 billion, show potential amid slight ASX gains. Diatreme focuses on mineral exploration but is pre-revenue, having reduced annual losses by 24.7%. It maintains a positive cash position but faces a short cash runway. Mesoblast, in regenerative medicine, generates significant revenue (A$65.38 million) and aims to improve its capital structure after a US$50 million loan. Its Phase 3 trial for a chronic low back pain treatment could drive future growth. Investors eyeing smaller ASX players might find these stocks promising due to their financial health and growth catalysts.

Latest News

Bloom Energy (NYSE:BE) trades choppy after Russell Top 200 adds the AI play

Bloom Energy (NYSE:BE) trades choppy after Russell Top 200 adds the AI play

25 June 2026
Bloom Energy plunged 5.2% as it prepares to exit the Russell 2000 and join the Russell Top 200 after a 1,000% stock surge, forcing index funds to rebalance amid a $15 billion one-day equity swing; at $309.18, shares trade 24 times the midpoint of its 2026 revenue guide, still 12% above Barclays’ new target.
Figma drops ahead of Russell close with valuation gap stretching

Figma drops ahead of Russell close with valuation gap stretching

25 June 2026
Figma (NYSE:FIG) plunged 9.8% to $16.84—just above its 52-week low—on heavy volume ahead of its addition to the Russell 3000 after Friday’s close, with index funds tracking $12.2 trillion set to rebalance; Figma now trades at about 5x its 2026 revenue guide, 49% below its IPO price, despite 46% Q1 revenue growth and raised guidance, as analysts cite mixed ratings and persistent losses.
Bitcoin Holds $80,000 as ETF Outflows Put Rally Back on Trial

Bitcoin slips near $59,500 as ETF outflows hit options support

25 June 2026
U.S. spot bitcoin ETFs saw $469 million in net outflows on June 24, with IBIT and FBTC accounting for about 77% of the total, sending IBIT down 1.1% and MSTR plunging 9.3%; Citi says ETF flows explain 45% of weekly BTC return variation, highlighting outflows as a key signal for investor sentiment as bitcoin tests the high-$50,000s.
Go toTop